The consistent research findings revealing a positive correlation between elevated CCL11 levels, and the severity of sensorial intolerance and cognitive impairment underscore the need for further investigation into the significance of this cytokine in the context of ME/CFS and its potential value as a diagnostic and therapeutic biomarker (Figure 7). The gene discussed is CCL11; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.